Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Acute Febrile Illnesses Laboratory, Evandro Chagas National Institute of Infectious Diseases - Oswaldo Cruz Foundation, Av. Brasil, 4365, Rio de Janeiro, 21045-900, Manguinhos, Brazil.
BMC Oral Health. 2023 Sep 27;23(1):696. doi: 10.1186/s12903-023-03325-z.
Early studies have highlighted the possible development of dysgeusia and anosmia in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and these manifestations should be considered a potential indication of coronavirus disease 19 (COVID-19). As potential contributors to these symptoms, dentists should perform careful oral and oropharyngeal examinations and document suspicious oral lesions in patients with COVID-19, especially in those who complain of loss of taste and smell. The study's objective was to assess the prevalence of oral manifestations among ambulatory unvaccinated symptomatic patients with suspected COVID-19 during the acute phase of the disease.
This cross-sectional study evaluated oral manifestations in adults (aged ≥ 18 years) with suspected and confirmed SARS-CoV-2 infection. Chi-square and Fisher's exact tests were used to compare data between the groups (rRT-PCR-positive and rRT-PCR-negative patients).
One hundred thirty-six participants were included. Most were female (n = 79; 58.1%), with a mean age of 39.53 (± 14.17) years. Of these, 54 (39.7%) had a positive rRT-PCR test, and 82 (60.3%) had negative rRT-PCR results. Oral manifestations were observed in 40 participants (74.1%) in the rRT-PCR-positive group and 67 participants (81.7%) in the rRT-PCR-negative group. The most common oral manifestations were xerostomia (n = 85; 62.5%) and dysgeusia/ageusia (n = 57; 41.9%). Different rates of gingivitis (n = 12; 22.2% vs. n = 5; 6.1%; p = 0.005) and halitosis (n = 7; 13.0% vs. n = 1; 1.2%; p = 0.007) were observed between the rRT-PCR-positive and -negative groups, respectively. Mouth ulcers, glossitis, tongue coating, and petechiae were reported in both groups without significant differences.
A high prevalence of oral manifestations was observed in symptomatic patients with suspected or confirmed COVID-19.
This study highlights the importance of routine oral examinations by dentists as part of the multidisciplinary care of COVID-19 patients.
早期研究强调了严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染可能出现味觉障碍和嗅觉障碍,这些表现应被视为 2019 年冠状病毒病(COVID-19)的潜在指征。由于这些症状的潜在原因,牙医应在 COVID-19 患者中进行仔细的口腔和口咽检查,并记录可疑的口腔病变,尤其是那些抱怨味觉和嗅觉丧失的患者。本研究的目的是评估在疾病急性阶段,疑似 COVID-19 的未接种疫苗的有症状门诊患者中口腔表现的流行率。
本横断面研究评估了疑似和确诊 SARS-CoV-2 感染的成年(年龄≥18 岁)患者的口腔表现。使用卡方检验和 Fisher 确切概率法比较两组(rRT-PCR 阳性和 rRT-PCR 阴性患者)的数据。
共纳入 136 名参与者。大多数为女性(n=79;58.1%),平均年龄为 39.53(±14.17)岁。其中,54 名(39.7%)rRT-PCR 检测呈阳性,82 名(60.3%)rRT-PCR 检测呈阴性。rRT-PCR 阳性组中 40 名(74.1%)和 rRT-PCR 阴性组中 67 名(81.7%)患者出现口腔表现。最常见的口腔表现为口干(n=85;62.5%)和味觉障碍/味觉丧失(n=57;41.9%)。rRT-PCR 阳性组和 rRT-PCR 阴性组的牙龈炎发生率(n=12;22.2%比 n=5;6.1%;p=0.005)和口臭发生率(n=7;13.0%比 n=1;1.2%;p=0.007)分别存在差异。两组均报告有口腔溃疡、舌炎、舌苔和瘀点,但无统计学差异。
疑似或确诊 COVID-19 的有症状患者口腔表现的流行率较高。
本研究强调了牙医进行常规口腔检查的重要性,这是 COVID-19 患者多学科护理的一部分。